Generic Name and Formulations:
Potassium (as bicarbonate and citrate) 10mEq, 20mEq, 25mEq; effervescent tabs for soln; unflavored, cherry vanilla, orange cream, lemon citrus, cherry berry flavors.
Indications for EFFER-K:
Hypokalemia with or without metabolic alkalosis. Digitalis intoxication. Hypokalemic familial periodic paralysis. Prevention of potassium depletion when dietary intake is inadequate.
Take with food or immediately after a meal; sip slowly over 5–10 mins. 1 tab 1–4 times daily, based on patient requirement. Dissolve each 10mEq tab in 2–3oz of cold water or juice (if unflavored); dissolve each 20mEq tab in 3–4oz of cold water or juice (if unflavored); dissolve each 25mEq tab in 4oz of cold water or 12–16oz of cold juice (if unflavored).
Hyperkalemia. Chronic renal disease. Metabolic acidosis. Uncontrolled diabetes mellitus. Esophageal compression. Delayed gastric emptying. Intestinal obstruction/stricture. Peptic ulcer. Concomitant potassium-sparing diuretics (eg, spironolactone, triamterene).
Discontinue if GI bleed, ulceration, or other disturbances occur. Acidosis. Renal or cardiac disease. Monitor serum potassium and magnesium levels, renal function, clinical status, acid-base balance, and ECG. Elderly. Pregnancy (Cat.C). Nursing mothers.
Hyperkalemia with potassium-sparing diuretics, ACE inhibitors, NSAIDs, beta-adrenergic blockers, heparin, low-salt foods, potassium-containing drugs, digitalis glycosides, others.
Hyperkalemia, nausea, vomiting, abdominal discomfort, diarrhea.
Tabs 10mEq, 20mEq—30; 25mEq—30, 100 (orange-flavored)
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)